Clinical trial · Interventional
Robotic Versus Laparoscopy NOSE for Stage I-III Left-sided Colon Cancer
Functional Recovery and Oncologic Efficacy of Robotic Versus Laparoscopy NOSE for Patients With Stage I III Left Sided Colon Cancer: A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this project, the investigator aims to provide the level 1 evidence for the comparison of robotic versus laparoscopic NOSE for the surgery of stage I-III colorectal cancer. the investigator hypothesize that, with the increased maneuverability of the current robotic system, robotic surgery will be a good option for patients with stage I-III colorectal cancer requiring a NOSE procedure.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Colectomy with NOSE procedure | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Laparoscopic surgery
- description
- The patients in this group will undergo laparoscopic surgery.
- interventionNames
- Procedure: Colectomy with NOSE procedure
- type
- ACTIVE_COMPARATOR
- label
- Robotic surgery
- description
- The patients in this group will undergo robotic surgery.
- interventionNames
- Procedure: Colectomy with NOSE procedure
Primary outcomes (1)
- measure
- The surgical efficiency of both NOSE procedures
- timeFrame
- Intraoperative hours with an average of 5 hours
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Primary colon cancers located at the left sided colonic anatomic location, including distal transverse colon, colonic splenic flexure, descending colon, sigm oid descending colonic junction, sigmoid colon and upper rectum that required the mobilization of colonic splenic flexure to facilitate a curative resection and trans anal specimen extraction ; 2. TNM Stage I III adenocarcinomas; 3. Curative and elective surgery; 4. American Society of Anesthesiology (ASA) class I to III patients; 5. Age \>18 years. Exclusion Criteria: 1. Cecal, ascending, the proximal and middle transverse colon cancers; and the middle or lower rectal cancers; 2. Emergency or palliative surgery; 3. Evidence of disseminated disease or adjacent organ invasion; 4. Primary tumor mass \>8 cm in diameter; 5. Morbidly obese patients, that is, body mass index (BMI) ≥40 kg/m 2 ; 6. Previous major surgery of upper abdomen or pelvis
References
Publications (0)
Data not yet available